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AbstrAct
Objectives In a randomised controlled trial, we found 
that informing women about overdetection changed their 
breast screening decisions. We now present a mediation 
analysis exploring the psychological pathways through 
which study participants who received the intervention 
processed information about overdetection and how this 
influenced their decision-making. We examined a series 
of potential mediators in the causal chain between 
exposure to overdetection information and women’s 
subsequently reported breast screening intentions.
Design Serial multiple mediation analysis within a 
randomised controlled trial.
setting New South Wales, Australia.
Participants 811 women aged 48–50 years with no 
personal history of breast cancer.
Interventions Two versions of a decision aid giving 
women information about breast cancer deaths averted 
and false positives from mammography screening, either 
with (intervention) or without (control) information on 
overdetection.
Main outcome Intentions to undergo breast cancer 
screening in the next 2–3 years.
Mediators Knowledge about overdetection, worry about 
breast cancer, attitudes towards breast screening and 
anticipated regret.
results The effect of information about overdetection 
on women’s breast screening intentions was 
mediated through multiple cognitive and affective 
processes. In particular, the information led to 
substantial improvements in women’s understanding 
of overdetection, and it influenced—both directly and 
indirectly via its effect on knowledge—their attitudes 
towards having screening. Mediation analysis showed 
that the mechanisms involving knowledge and attitudes 
were particularly important in determining women’s 
intentions about screening participation.
conclusions Even in this emotive context, new 
information influenced women’s decision-making by 
changing their understanding of possible consequences 
of screening and their attitudes towards undergoing it. 
These findings emphasise the need to provide good-
quality information on screening outcomes and to 
communicate this information effectively, so that women 
can make well-informed decisions.
trial registration number This study was prospectively 
registered with the Australian New Zealand Clinical Trials 
Registry (ACTRN12613001035718) on 17 September 
2013.
IntrODuctIOn
Breast cancer screening is a complex 
and emotionally charged issue,1 a topic 
surrounded by what has been described as a 
perfect storm of politics and science.2 While 
screening can reduce deaths from breast 
cancer, it can also cause harm through the 
counterintuitive phenomenon of overdetec-
tion or overdiagnosis. The term overdetec-
tion is increasingly accepted in the specific 
context of screening to distinguish it from 
overdiagnosis that occurs via other mecha-
nisms, such as broadening disease definitions. 
An overdetected breast cancer is one found 
by screening, and consequently treated, 
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Research
strengths and limitations of this study
 ► Random allocation between two decision aids, 
differing only in the presence or absence of 
information about overdetection, enabled a rigorous 
test of the specific effects of this information 
when described in the context of other screening 
outcomes.
 ► Participants were women entering the target age 
range for breast screening, who were sampled 
randomly from the general community and were 
facing real decisions.
 ► Our serial mediation model controlled for a 
comprehensive set of baseline variables and 
examined plausible, theory-driven cause–effect 
relationships between exposure to the intervention 
and subsequently measured variables.
 ► Nonetheless, given the cross-sectional nature of the 
outcome and mediator data, we cannot definitively 
establish the causal sequence of these variables.
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that would not have caused any health problems had it 
been left undetected and untreated.3 Without screening, 
such a cancer would never have been diagnosed. Over-
detected cancers are ‘real’ cancers in the sense that they 
meet current pathological criteria for cancer diagnosis, 
but finding and treating them does not improve health 
outcomes. Such a diagnosis and the resulting treatment 
can cause serious lifelong harm, and overdetection is, 
therefore, considered the major downside to breast 
screening.
Mounting evidence of the extent of overdetection 
(estimated as 19% of breast cancers diagnosed in women 
invited to screen from age 50 to 69 years4 and 30% for 
those who attend screening5) has led to recognition that 
the benefits and harms of breast screening are finely 
balanced for women at population-level risk of breast 
cancer. The risk of overdetection and its consequences 
must be weighed against the benefit of reducing breast 
cancer mortality (relative risk reduction estimated as 20% 
for women invited to screen from age 50 to 694 and 30% 
for those screened5). Experts familiar with the evidence 
now acknowledge that individual women may perceive 
the harm-benefit trade-off differently depending on their 
personal context and preferences—some will opt for 
screening while others decline, and either choice may 
be appropriate if it represents an informed decision.6–8 
Throughout the history of breast screening, however, 
women invited to participate have not been given all 
the relevant information.9–11 Consensus is growing that 
information on screening benefits and harms, including 
overdetection, must be communicated clearly and trans-
parently to women offered screening so that they can make 
informed decisions about whether to be screened.4 12 13 
This is all the more important because of evidence that 
women hold misconceptions about breast screening and 
its effects.14 15
Against the background of this recommended shift in 
communication, the issue of how information about over-
detection affects women and their screening decisions 
is critical. In a randomised trial, we addressed this ques-
tion in women approaching the recommended age for 
starting mammography screening (age 50, when women 
are invited for screening in many countries including 
Australia).16 We sent women one of two versions of a 
decision aid (evidence-based information booklet) giving 
information about breast cancer deaths averted and 
false positives from screening (abnormal mammograms 
in women without cancer), either with or without infor-
mation on overdetection.17 The intervention produced 
several significant effects on decision-making.16 The addi-
tional overdetection information improved knowledge, 
increased the number of women making an informed 
choice about screening (primary outcome of the trial), 
and also reduced positive attitudes to screening and the 
number of women intending to be screened.16
From our study design— chosen to identify the specific 
impact of information about overdetection—it appears 
that communicating this information influenced women’s 
assessment of the value of screening to them, leading to 
lower intentions to be screened within the intervention 
group. This finding has never been observed before and 
raises important questions. To facilitate the translation of 
intervention research findings into other contexts, it is 
recommended to test hypothesised causal mechanisms.18 
However, causal processes leading from the use of deci-
sion aids to the decisions subsequently made are not 
well understood, as few studies have addressed questions 
about how these interventions achieve their effects.19 Only 
recently have decision aid developers started to critically 
examine in detail how behavioural, cognitive and social 
theories of decision-making could inform the design and 
evaluation of decision support interventions.20 In this 
paper, we explore the psychological pathways through 
which study participants processed overdetection infor-
mation and integrated it into their decision-making. We 
provide an explanatory account incorporating cognitive 
and affective pathways, using psychological theories21 and 
mediation analysis.22
MethODs
We did a parallel-group randomised controlled trial with 
women aged 48–50 years, recruited from the general 
community in New South Wales, Australia. The trial is 
described in detail elsewhere.16 23 Trained interviewers 
from an independent non-profit company recruited 
participants via telephone. Women were eligible if they 
had not undergone mammography in the past 2 years 
and did not have a personal or strong family history of 
breast cancer. Participants knew that they would receive 
one of two versions of a breast screening information 
booklet but did not know how these differed or which 
was the intervention.
We collected sociodemographics and baseline data 
on women’s stage of decision-making (how far along 
they were with their decision about breast screening), 
basic conceptual knowledge, attitudes and intentions 
(table 1).16 23 We then randomly assigned 879 women to 
the intervention (n=440) or control group (n=439) and 
sent their allocated decision aid by post. A programmer 
who had no contact with participants generated the 
randomisation sequence, which was inaccessible until 
after recruitment, ensuring allocation concealment.
The intervention decision aid contained evidence-
based explanatory and quantitative information about 
important outcomes of undergoing screening biennially 
from age 50 to 69 years (breast cancer mortality reduc-
tion, overdetection and false positives) compared with 
not screening over this period. The control decision 
aid omitted all overdetection content but was otherwise 
identical to the intervention. The decision aids were 
short booklets combining text and visual formats and are 
published.16 17
Our purpose in the analysis reported here was to 
explore causal pathways between exposure to informa-
tion about overdetection in a decision aid (intervention) 
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Table 1 Baseline sample characteristics (N=811)
Variable
Intervention group
(n=406)
Control group
(n=405)
Sociodemographics n (%) n (%)
Family history of breast cancer
  No close blood relative ever diagnosed 389 (96) 386 (95)
  One close blood relative diagnosed aged ≥50 years 17 (4) 19 (5)
Country of birth
  Australia or New Zealand 327 (81) 335 (83)
  Other 79 (19) 70 (17)
Main language spoken at home
  English 390 (96) 396 (98)
  Other 16 (4) 9 (2)
Education
  School only or trade certificate 226 (56) 225 (56)
  Diploma or university degree or higher 180 (44) 180 (44)
Marital status
  Married or living with a partner 317 (78) 333 (82)
  Not currently living with a partner 89 (22) 72 (18)
Parent status
  Has one or more children 361 (89) 363 (90)
  No children 45 (11) 42 (10)
Work status
  Working full time or part time 333 (82) 341 (84)
  No paid job currently 73 (18) 64 (16)
Age
  48–49 years 289 (71) 294 (73)
  50 years 117 (29) 111 (27)
Preintervention measures Mean (SD) Mean (SD)
Stage of decision-making about screening 3.4 (1.0) 3.4 (0.9)
Knowledge (basic concepts of screening) 4.4 (0.8) 4.4 (0.8)
Baseline attitudes to breast screening 26.5 (3.6) 26.8 (3.6)
Baseline intentions about screening 4.5 (0.8) 4.6 (0.8)
All baseline variables appearing above were included as covariates in the mediation analysis (sociodemographic factors were dichotomised 
as shown). Possible ranges: stage of decision-making 1 (not yet thought about the options) to 4 (already made a choice), knowledge 0 (none 
correct) to 5 (all correct), attitudes 6 (least positive) to 30 (most positive), intentions 1 (definitely not) to 5 (definitely).
and subsequent breast screening intentions (outcome). 
We examined a series of potential mediators of this rela-
tionship: knowledge about overdetection, worry about 
breast cancer, attitudes towards breast screening and 
anticipated regret. We collected follow-up data for these 
variables using standardised questions in a structured 
postintervention telephone interview, 1–4 weeks after 
randomisation. The participant’s group assignment was 
unknown to the interviewer until the end of the interview.
Our postintervention knowledge scale assessed concep-
tual understanding of three key screening outcomes 
(breast cancer mortality reduction, overdetection 
and false positives) and awareness of the approximate 
numbers affected.16 For the mediation analysis, we used 
the overdetection knowledge subscale (scored 0–10, 
including conceptual and numeric components) because 
conveying this new information was the main aim of the 
intervention. We assessed attitudes to breast screening via 
a widely used 6-item instrument (possible range: 6–30), 
intentions to undergo screening in the next 2–3 years (1 
item, 5-point response scale from definitely to definitely 
not) and worry about developing breast cancer (1 item, 
4-point scale).16 23 24 Higher scores on these measures 
reflect better knowledge, more positive attitudes and 
intentions, and greater worry, respectively. We collected 
women’s anticipated regret both for screening (antici-
pating that if she undergoes screening (action) she may 
later wish she had not) and not screening (anticipating 
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Table 2 Means and SDs for study groups on screening 
intentions and mediator variables
Variable
Intervention 
group
(n=406)
Control 
group
(n=405)
Mean (SD) Mean (SD) p Value
Overdetection 
knowledge
6.2 (2.2) 4.0 (1.6) <0.001
Breast cancer worry 1.7 (0.7) 1.8 (0.7) <0.001
Screening attitudes 24.5 (4.4) 26.1 (4.1) <0.001
Anticipated regret 1.9 (1.7) 2.5 (1.6) <0.001
Screening intentions 4.1 (1.1) 4.5 (0.9) <0.001
Possible score ranges were as follows: overdetection knowledge 
0–10, breast cancer worry 1–4, attitudes 6–30, anticipated regret 
−4 to 4, intentions 1–5. See (online supplementary appendix 1)  for 
further details on measures. Groups were compared here using 
t-tests.
that if she does not undergo screening (inaction) she may 
later wish she had).25 We then calculated a differential 
anticipated regret score26 by subtracting the action from 
the inaction score. Higher scores on the resulting measure 
(possible range: –4 to 4) reflect greater anticipated regret 
for not screening, adjusted for the woman’s anticipated 
regret for screening. See the (online supplementary 
appendix 1)for further details about these measures.
We tested whether these variables functioned in a chain 
with a specified direction of causal flow (serial media-
tion).22 Based on health psychology theories (eg, theory 
of planned behaviour27 28) we tested the following causal 
chain: intervention (group allocation) → overdetec-
tion knowledge → worry → attitudes → anticipated regret 
→ intentions. One could hypothesise, for example, that 
exposure to information (if communicated effectively) 
should increase knowledge about overdetection. Under-
standing that some breast cancers would not cause harm 
even if untreated might reduce worry about breast cancer, 
which may affect attitudes towards screening. Anticipa-
tion of feeling regret if one does not (vs does) undergo 
screening might depend on attitudes and in turn influ-
ence intentions.
Mediation models were tested using model 6 in the 
PROCESS macro (V.2.16) for SPSS (V.24).22 This proce-
dure applies an ordinary least squares path analytic frame-
work to estimate both direct and indirect effects (IEs) of 
the intervention on screening intentions. To derive these 
effects, PROCESS fits a series of linear regression models 
with each variable treated as the outcome in turn. The 
regression coefficients estimate how each variable affects 
other variables later in the sequence. Baseline variables 
in table 1 (all measured preintervention, including base-
line screening intentions) were statistically controlled 
by including them as covariates during mediation anal-
yses. Outcome and mediator variables were standardised 
(expressed in units of SD from the sample mean) for 
the mediation analysis. We used a bootstrapping proce-
dure in order to conduct inference tests for the IEs. This 
involved repeatedly drawing samples (with replacement) 
of size n (where n equals the original sample size) from 
the existing data, and then estimating the IE in each 
re-sampled dataset. By repeating this process thousands 
of times, PROCESS generated an empirical approxima-
tion of the underlying sampling distribution of the IE 
which was then used to construct a CI for the effect. In 
this study, 50 000 bootstrap samples were used to create 
95% bias-corrected CIs (95% CIs) for the IEs, which we 
considered significant if the CI did not include zero.
results
Of 879 participants randomised, 838 completed the 
follow-up interview. Among these, 27 did not answer all 
relevant questions and were excluded from the medi-
ation analysis. Sociodemographic characteristics were 
similar for randomised participants who were and were 
not included in the mediation analysis. Table 1 shows 
baseline characteristics of the 811 included participants, 
which were well balanced between the intervention and 
control groups.
Table 2 presents mean postintervention scores for inter-
vention and control groups on the variables included in 
the mediation model. Compared with controls, the inter-
vention group showed greater knowledge about over-
detection, lower worry about breast cancer, less positive 
attitudes towards breast screening, lower anticipated 
regret for not screening (vs for screening) and lower 
intentions to undergo screening. Correlations between 
these variables were significant (p<0.001) as shown in the 
(online supplementary appendix).
Serial mediation analysis found that the total IE of 
the intervention on intentions was statistically signifi-
cant, indicating that the intervention influenced inten-
tions indirectly through its effects on the combined set 
of mediators. Reading the intervention rather than the 
control decision aid was associated with a decrease in 
screening intentions as a result of all specific indirect 
causal sequences in the model (table 3). As the direct 
effect was not significant, there was no evidence that 
the intervention affected intentions independently of its 
influence on the mediators modelled.
The specific path coefficients are shown in figure 1. 
The figure illustrates, for example, that participants who 
received the intervention decision aid demonstrated 
greater knowledge than controls, participants with 
greater knowledge expressed less positive attitudes and 
participants with less positive attitudes also had less posi-
tive intentions.
Table 3 presents effect estimates and 95% CIs for the 
15 specific IEs representing causal pathways through the 
various mediator sequences. The main significant IEs 
of the intervention on intentions were those involving 
knowledge and attitudes as mediators, both separately 
(IE1, IE13 in table 3) and together in sequence (IE3). 
The first specific IE (IE1) tested whether overdetection 
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Table 3 Direct and indirect effects (IEs) of the intervention on intentions via four sequential mediators
Path Effect SE 95% CI
Total effect −0.2768 0.0540 −0.3828 −0.1708
Direct effect −0.0192 0.0501 −0.1175 0.0791
Total IE −0.2576 0.0449 −0.3488 −0.1734
Specific IEs
  1. Knowledge −0.0731 0.0267 −0.1281 −0.0230
  2. Knowledge, worry −0.0010 0.0017 −0.0073 0.0007
  3. Knowledge, attitudes −0.0700 0.0171 −0.1071 −0.0396
  4. Knowledge, anticipated regret −0.0201 0.0072 −0.0375 −0.0088
  5. Knowledge, worry, attitudes −0.0001 0.0007 −0.0023 0.0011
  6. Knowledge, worry, anticipated regret −0.0004 0.0005 −0.0021 0.0002
  7. Knowledge, attitudes, anticipated regret −0.0121 0.0040 −0.0220 −0.0059
  8. Knowledge, worry, attitudes, anticipated regret −0.0000 0.0001 −0.0004 0.0021
  9. Worry −0.0047 0.0050 −0.0191 0.0021
  10. Worry, attitudes −0.0003 0.0027 −0.0063 0.0046
  11. Worry, anticipated regret −0.0020 0.0014 −0.0063 −0.0003
  12. Worry, attitudes, anticipated regret −0.0001 0.0005 −0.0012 0.0008
  13. Attitudes −0.0618 0.0285 −0.1178 −0.0065
  14. Attitudes, anticipated regret −0.0106 0.0056 −0.0241 −0.0016
  15. Anticipated regret −0.0012 0.0104 −0.0216 0.0200
N=811; 50 000 bootstrap samples; bias-corrected CIs. The sequential mediators are: overdetection knowledge, breast cancer worry, attitudes, 
anticipated regret. Bold effects are significant (p<0.05).
knowledge mediated the relationship between the deci-
sion aid received and subsequent breast screening inten-
tions; this effect was significant. Relative to those assigned 
to the control decision aid, participants receiving the 
intervention demonstrated better knowledge about over-
detection and consequently expressed lower intentions to 
have screening. Another significant effect, IE13 showed 
that the intervention resulted in less positive attitudes, 
which also led to lower screening intentions. IE3 tested 
the causal chain: intervention → knowledge → attitudes 
→ intentions. This was also significant and demonstrated 
that participants exposed to the intervention gained 
better overdetection knowledge, those with better knowl-
edge had less positive attitudes, and these attitudes were 
in turn associated with reduced intentions to screen. Pair-
wise contrasts revealed that the three largest specific IEs 
(IE1, IE3 and IE13) did not significantly differ in size.
The anticipated regret variable was also involved in 
several significant mediation pathways, influenced by 
knowledge and attitudes separately (IE4, IE14) and 
together (IE7). The most complex of the significant 
IEs was IE7 leading from the intervention → overdetec-
tion knowledge → screening attitude → anticipated regret 
→ screening intention. Compared with the control 
group, women receiving the intervention had greater 
overdetection knowledge, which led to less positive atti-
tudes (as above); these were in turn associated with lower 
anticipated regret for not screening (vs screening), which 
translated into reduced intentions to screen.
The specific IE for the pathway through the complete 
causal chain involving all four mediators in sequence 
(IE8)—that is, adding breast cancer worry to the medi-
ators discussed above—was not significant. Worry was 
part of only one significant IE (IE11). The intervention 
reduced breast cancer worry; women with lower worry 
had lower anticipated regret for not screening, which 
again reduced screening intentions.
DIscussIOn
This study showed that the relationship between exposure 
to information on overdetection and women’s subsequent 
breast screening intentions was mediated by multiple 
cognitive and affective pathways. The intervention deci-
sion aid substantially improved understanding of overde-
tection, and it influenced—both directly and indirectly 
via its effect on knowledge—women’s attitudes towards 
having screening. The mediation analysis revealed that 
these mechanisms involving knowledge and attitudes 
were particularly important in determining intentions 
about screening participation. Anticipated regret played 
a role in several additional pathways linking knowledge, 
attitudes and intentions. As women became more knowl-
edgeable about overdetection and their screening atti-
tudes became less positive, this lessened their expectation 
that not screening would cause regret and increased the 
realisation that screening might cause regret, which in 
turn influenced intentions. The non-significance of the 
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Figure 1 Graphic representation of the serial multiple 
mediation model of decision aid effects on breast screening 
intentions via four sequential mediators (overdetection 
knowledge, breast cancer worry, screening attitudes and 
anticipated regret). The intervention was hypothesised to 
exert an effect on screening intentions through the four 
mediators in sequence. Outcome and mediator variables 
were standardised prior to analysis. Bold coefficients 
are significant (p<0.05). Analyses controlled for baseline 
measures including screening intentions and attitudes, basic 
screening knowledge, stage of decision-making, breast 
cancer family history, birthplace, main language spoken, 
education, marital status, parent status, work status and age.
direct effect (ie, relationship between study group and 
intentions after adjusting for all mediators) confirms 
that our model captured the key relevant constructs, 
suggesting little of the observed total effect was due to 
other differences between the intervention and control 
decision aids (eg, length, newness of information and 
time spent reading).
The randomised controlled trial design is a key strength 
of this study. Random allocation between two decision 
aids, differing only in the presence or absence of infor-
mation about overdetection, enabled a rigorous test of 
the specific effects of this information when described 
in the context of other screening outcomes. Our serial 
mediation model controlled for a comprehensive set of 
baseline variables and examined plausible, theory-driven 
cause–effect relationships between exposure to the inter-
vention and subsequently measured variables. Nonethe-
less, a limitation is that given the cross-sectional nature 
of the outcome and mediator data, we cannot definitively 
establish the causal sequence of these variables. While 
some of the group differences shown in table 2 are small, 
our purpose in this article was not to establish the clin-
ical significance of such differences (see elsewhere for 
more detailed analysis16) but rather to explore possible 
causal mechanisms involved. Whether the outcome vari-
ables in the serial mediation model are normally distrib-
uted or not, the inferences are likely to remain valid due 
to the large sample size of the study.22 29 Participants 
had not been screened in the 2 years prior to the study 
and were close to the age (50 years) at which women 
are invited into the Australian national breast screening 
programme. Intervention effects could vary in other 
populations depending on age and cultural context. For 
example, providing information about overdetection to 
women who already have more personal experience with 
screening (eg, women in their 60s) might produce less of 
an effect on attitudes and intentions, as suggested by our 
previous qualitative research.30
Although previous literature has reported on screening 
decisions aided by decision support techniques,31 32 
little work to date has examined mechanisms for how 
information provided in such resources translates into 
decisions. Our mediation findings are in line with the 
explanatory account of health decisions offered by the 
theory of planned behaviour.27 28 Under this theory, 
attitudes towards a behaviour are determined by salient 
beliefs about its consequences (in this case, the under-
standing conveyed by the decision aid that overdetection 
is a possible consequence of screening); these attitudes 
in turn determine intentions. Our observed mediation 
effects involving anticipated regret accord with other 
empirical evidence supporting its usefulness as an exten-
sion to the theory of planned behaviour.33 Worry about 
the threat of breast cancer, though emphasised by other 
health psychology theories, did not appear to play a 
major role in determining screening intentions among 
our study participants. While the power of emotion has 
been cited as a challenge for communicating harms of 
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mammography,34 our findings reinforce the vital role 
of good educational materials by demonstrating how 
evidence-based information influenced women’s cogni-
tions about screening and showing that cognitions, rather 
than emotions, were instrumental in decision-making. 
Using a theoretical basis in behavioural psychology or 
decision-making theory is often overlooked but may 
strengthen the design and evaluation of decision support 
materials, although operationalising such theories can 
be challenging.20 There is a need to develop and employ 
comprehensive theoretical frameworks that help us better 
understand the role of comprehension of benefits and 
harms in shaping informed screening decisions, as well 
as how external factors—such as conflicting information 
from different sources—may influence both informa-
tion processing and decision-making in this sometimes 
controversial area.2 35–37
cOnclusIOns
We have previously shown that giving women evidence-
based written information about overdetection in breast 
screening can change women’s screening intentions. 
Importantly, for the first time we now provide evidence, 
using mediation analysis, of how this cognitive and affec-
tive process works: the decision aid intervention achieved 
substantial knowledge gains, and thereby influenced 
attitudes and intentions towards screening. Our find-
ings underline the importance of providing good-quality 
information to women when they are invited to consider 
screening, using materials with the capacity to successfully 
impart new and relevant knowledge. Effective communi-
cation tools and decision support resources are especially 
needed against a background of widely documented 
unrealistic public expectations of screening which may 
be driven by psychological factors in combination with 
sometimes misleading messages about benefits and lack 
of attention to harms.38 39 Our findings are a reminder 
that information can be a powerful intervention, and that 
the development of information resources must be done 
properly with rigour and care.
twitter @jolynhersch @wiserhealthcare
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